MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

PharMerica Company Profile (NYSE:PMC)

Consensus Ratings for PharMerica (NYSE:PMC) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $32.33 (32.35% upside)

Analysts' Ratings History for PharMerica (NYSE:PMC)
Show:
DateFirmActionRatingPrice TargetActions
3/15/2016Credit SuisseInitiated CoverageOutperform$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016Barrington ResearchReiterated RatingOutperform$39.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016KeyBancLower Price TargetOverweight$39.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016BarclaysLower Price TargetUnderweight$27.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2015Cowen and CompanyReiterated RatingBuy$39.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2015Bank of AmericaReiterated RatingBuy$34.00 -> $39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/11/2014Goldman SachsInitiated CoverageNeutral$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2014Evercore ISIReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/4/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha